Oxaliplatin retreatment in metastatic colorectal cancer: Systematic review and future research opportunities.
Mauri Gianluca, Gori Viviana, Bonazzina Erica, +9 more·Cancer treatment reviews
BACKGROUND: Oxaliplatin represents a main component of cytotoxic treatment regimens in colorectal cancer (CRC). Given its efficacy, oxaliplatin is frequently re-administered in the context of the continuum of care in metastatic CRC (mCRC). However, efficacy and tolerability of this therapeutic strategy has not been com…